Clinical Trial Update: Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial assessing transepicardial with transseptal autologous CD133+ bone marrow cell implantation after CABG in coronary artery disease; completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CD133+ autologous bone marrow cells (CD133+ autologous bone marrow cell implantation)

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-04-02